Exact Mass: 647.2438367999999
Exact Mass Matches: 647.2438367999999
Found 52 metabolites which its exact mass value is equals to given mass value 647.2438367999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
BGC 945; ONX 0801
C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor
N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid
Ala Trp Trp Trp
Glu Gln Trp Trp
C32H37N7O8 (647.2703482000001)
Glu Trp Gln Trp
C32H37N7O8 (647.2703482000001)
Glu Trp Trp Gln
C32H37N7O8 (647.2703482000001)
Gln Glu Trp Trp
C32H37N7O8 (647.2703482000001)
Gln Trp Glu Trp
C32H37N7O8 (647.2703482000001)
Gln Trp Trp Glu
C32H37N7O8 (647.2703482000001)
Trp Ala Trp Trp
Trp Glu Gln Trp
C32H37N7O8 (647.2703482000001)
Trp Glu Trp Gln
C32H37N7O8 (647.2703482000001)
Trp Gln Glu Trp
C32H37N7O8 (647.2703482000001)
Trp Gln Trp Glu
C32H37N7O8 (647.2703482000001)
Trp Trp Ala Trp
Trp Trp Glu Gln
C32H37N7O8 (647.2703482000001)
Trp Trp Gln Glu
C32H37N7O8 (647.2703482000001)
Trp Trp Trp Ala
Cloperastine fendizoate
C40H38ClNO5 (647.2438367999999)
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Lercanidipine hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
sulfosuccinimidyl n-[n-(d-biotinyl)-6-aminohexanoyl]-6-aminohexanoate
C26H41N5O10S2 (647.2294726000001)
N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid
(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumylheptanedioate
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide
C30H37N3O9S2 (647.1971112000001)
N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid
C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor
(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-)
A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.
16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-)
A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of 16(S)-glutathionyl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid; major species at pH 7.3.
5'-O-DMT-N4-Bz-5-Me-dC
C38H37N3O7 (647.2631372000001)
5'-O-DMT-N4-Bz-5-Me-dC is a modified nucleoside. 5'-O-DMT-2'-O-TBDMS-rI can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
n-[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
C31H37NO14 (647.2213942000001)
(3s,4s)-3-[(2r,3r,4r,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyl-5-[(1r)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,4-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
3-{6-[(acetyloxy)methyl]-3,5-dihydroxy-4-[(5-hydroxy-4-methoxy-6-methyl-5-{1-[(2-methylpropanoyl)oxy]ethyl}oxan-2-yl)oxy]oxan-2-yl}-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
(3s)-3-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid
[(2s,3s,4r,5s)-5-{[(1r,2s,3r,4r,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2-methyloxolan-3-yl]methoxyphosphonic acid
{[(2r,3s,5s,6r,7s,8z,10s,11s,12z,14z)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid
({22,26-dihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-16-oxo-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,18(26),19(24),22-heptaen-10-yl}oxy)methanimidic acid
{[(2r,3s,5s,6r,7s,8e,10s,11s,12z,14e)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid
(5s)-5-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid
n-[2-({2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
C31H37NO14 (647.2213942000001)